SICKLE CELL DISEASE (SCD)
Clinical trials for SICKLE CELL DISEASE (SCD) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL DISEASE (SCD) trials appear
Sign up with your email to follow new studies for SICKLE CELL DISEASE (SCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising sickle cell drug moves to kids: could cut painful episodes
Disease control CompletedThis study tested the safety and best dose of a drug called crizanlizumab in children aged 2 to 18 with sickle cell disease who have had painful crises. The drug aims to reduce these pain episodes by blocking cells from sticking to blood vessels. 117 children received the drug fo…
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug shows promise in reducing painful sickle cell crises
Disease control CompletedThis study looked at the safety of a drug called crizanlizumab in 140 Indian patients aged 16 and older with sickle cell disease who have had painful crises. The drug is meant to reduce the frequency of these crises. Researchers monitored serious side effects and other adverse ev…
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
ER wait after admission costs millions, study finds
Knowledge-focused CompletedThis study looked at over 30,000 adults hospitalized in Maryland to understand why some patients wait in the emergency room after being admitted (called boarding) and how that affects costs and care. Researchers analyzed existing medical records to find patterns and financial imp…
Matched conditions: SICKLE CELL DISEASE (SCD)
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC